.svg)
%20copy.jpeg)
Prescription pill bottles are among some of the most widely handled healthcare packaging formats in the U.S. and are typically made from high-density polyethylene (HDPE) and polypropylene (PP)—plastic resins with established recycling end markets. Despite this, most pill bottles are landfilled or incinerated at end-of-life.
Prescription pill bottles also sit at the intersection of two systems that are often analyzed separately: healthcare plastics and consumer packaging. Pill bottles are part of a highly regulated healthcare environment shaped by safety, compliance, secure handling and, in many cases, privacy considerations. Yet once dispensed to patients, many pill bottles function like small-format consumer packaging—a category that has historically low recovery rates in the U.S. due to collection, sorting and aggregation challenges. This dual nature makes pill bottle recovery both important and complex.
Given the challenges and opportunities for pill bottle recycling, and the Center’s previous work to identify recovery opportunities for small-format consumer packaging, we set out to clarify misconceptions, distinguish between pill bottle formats and handling environments, and identify practical pathways that can improve recovery over time without creating unintended operational or regulatory consequences.
Focusing on pill bottle recovery allows stakeholders to better understand where recovery is realistically possible now, where more system development is required, and how lessons learned might inform circular pathways for other healthcare plastics.
Rather than proposing a single solution, this report clarifies what recovery pathways are feasible today, what may become viable over time, and how stakeholders across the pharmaceutical and recycling value chains can take thoughtful action that can improve recovery outcomes over time without creating unintended operational, regulatory or reputational consequences.
